Dr. Ayla Kessler, MD

Dr. Kessler practices at Aspirus Wisconsin Rapids Hospital in Wisconsin Rapids, Wisconsin, part of Aspirus.

Dr. Kessler's NPI, 1437359585, was assigned on July 18, 2007. Dr. Kessler graduated from Mansoura University Faculty of Medicine in 2003. Dr. Kessler's North Carolina license number on file is 201501869.

Dr. Kessler's primary practice is Aspirus Wisconsin Rapids Hospital, at 410 Dewey St, Wisconsin Rapids, WI 54494 in Wood County. The practice phone is (715) 423-6060.

Dr. Kessler's primary practice is Aspirus Wisconsin Rapids Hospital in Wisconsin Rapids, Wisconsin, part of Aspirus. Dr. Kessler is also affiliated with Atrium Health Wake Forest Baptist Medical Center. The medical group on file is Ashe Memorial Hospital. Dmand AI also links Dr. Kessler to 3 more hospitals and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kessler practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Kessler's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Kessler is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Kessler's licenses on file in 5 states: North Carolina, Florida, Ohio, Wisconsin and New York.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, lung cancer, lymphoma, multiple myeloma and prostate cancer among the conditions Dr. Kessler treats.

CMS data shows 12 Medicare services from Dr. Kessler across 1 procedure code in 2024, all of them office visits, for 18 Medicare patients. Medicare paid $288 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 18 Medicare patients who saw Dr. Kessler in 2024. 72% of them have high cholesterol. Their average risk score is 1.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kessler's median patient age at 75, with 61% women.

In 2024, Dr. Kessler wrote 97 Medicare Part D claims for 34 patients. 68% of them were for generic drugs. CMS names the drug for 14 of them, across 1 drug with 11 or more claims each, at $9,633 in total drug cost. In 2023, CMS named 118 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Kessler for performance year 2024, reported as part of a group. Dr. Kessler accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links Dr. Kessler to 7 clinical trials, 4 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Breast Neoplasms, Triple Negative Breast Neoplasms and Breast Neoplasms, Male. Novartis Pharmaceuticals sponsors the most, 2.

CMS Open Payments shows 639 general payments to Dr. Kessler from 48 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 70% of the total. Pfizer Inc. paid the most, $4,533.

Dmand AI lists 1 award for Dr. Kessler, most recently CMS Stage 1 EHR in 2013.

Dr. Kessler graduated from Mansoura University Faculty of Medicine in 2003. Dr. Kessler is a member of ACP, AMA, ASCO and European Society of Medical Oncology.

Dr. Kessler is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.